You are here:
Marketing authorisations based on studies conducted by GVK Biosciences in India: suspension of marketing authorisation
2014.12.09
Active substance: various
In a notice dated 8 December 2014, the Federal Institute for Drugs and Medical Devices (BfArM) has ruled the suspension of several marketing authorisations that were based on a clinical trial conducted by GVK Biosciences in India.
To the graduated plan procedure (available in German only)